🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT05830825
Recruiting Observational

PMCF (Post-Market Clinical Follow-up) Study on The Tether™ in UK (United Kingdom)

NCT05830825 · tracked via the Priya Life Science UK tracker
Sponsor
LDR Médical SAS
Phase
Observational
Started
2024-07-18
Last updated
2026-07-21

Condition(s) studied

Scoliosis Idiopathic

Investigational drug(s) / intervention(s)

Vertebral Body Tethering (VBT)

Vertebral Body Tethering (VBT): Vertebral Body Tethering surgery with the Tether™ in UK

Study summary

The goal of this observational study is to collect information about The Tether™ device in participants with progressive idiopathic scoliosis, Lenke Type 1 curves. The main purpose is to provide assessment of:

* ongoing safety
* probable benefits Participants who will receive The Tether™ during spine surgery will have to attend follow-up visits which are part of standard-of-care.

Eligibility

Sex
ALL
Min age
0 Years
Max age
30 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of progressive idiopathic scoliosis; * Skeletally immature, based on both Risser (\<5) and Sanders (\<8) assessments; * Major Cobb angle ≥30° and ≤65°; * Osseous structure dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging; * Failed bracing and/or be intolerant to brace wear; * Lenke Type 1 curves (i.e., main thoracic); * Signed Informed Consent Form by legal guardian or by the patient if ≥ 16 years old. * The decision to treat patients with The Tether™ - VBT System was made by the patient's clinician outside of this research Exclusion Criteria: * Presence of any systemic infection, local infection, or skin compromise at the surgical site; * Prior spinal surgery at the level(s) to be treated; * Known poor bone quality defined as a T-score -1.5 or less; * Skeletal maturity; * Any other medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the implant materials, and patients unwillingness or inability to cooperate with post-operative care instructions; * Unwillingness, inability, or living situation (e.g., custody arrangements, homelessness, detention) that would preclude ability to return to the study site for follow-up visits as described in protocol and Informed Consent; * Patients who are pregnant at the time of enrollment.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Saint George's Hospital London United Kingdom Recruiting
Freeman Hospital Newcastle upon Tyne United Kingdom Recruiting
University Southampton Hospital Southampton United Kingdom Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05830825 on ClinicalTrials.gov ↗ ← All trials in the UK